TY - JOUR T1 - <sup>18</sup>F-FDG PET/CT imaging features of Cardiac Arrhythmia - induced by Panitumumab JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. DO - 10.2967/jnmt.121.262216 SP - jnmt.121.262216 AU - Pokhraj Prakashchandra Suthar AU - Khushboo Gupta AU - Jagadeesh S Singh Y1 - 2021/07/01 UR - http://tech.snmjournals.org/content/early/2021/07/30/jnmt.121.262216.abstract N2 - Panitumumab is a new humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advance colorectal cancer. Here we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving Panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with Panitumumab. By far to our knowledge, no documented imaging findings for the same are available in the literature. ER -